Factor Ii And Fibrinogen For Treatment Of Haemostatic Disorders - EP2624859

The patent EP2624859 was granted to Medimmune on Mar 1, 2017. The application was originally filed on Sep 19, 2011 under application number EP11761051A. The patent is currently recorded with a legal status of "Revoked".

EP2624859

MEDIMMUNE
Application Number
EP11761051A
Filing Date
Sep 19, 2011
Status
Revoked
Oct 23, 2020
Grant Date
Mar 1, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANNov 30, 2017D YOUNGADMISSIBLE

Patent Citations (24) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2003129183
DESCRIPTIONUS2004198647
DESCRIPTIONUS2004237970
DESCRIPTIONUS2005164367
DESCRIPTIONUS2005282771
DESCRIPTIONUS2006025336
DESCRIPTIONUS2006211621
DESCRIPTIONUS2007232788
DESCRIPTIONUS2008014251
DESCRIPTIONUS2008188400
DESCRIPTIONUS2008267940
DESCRIPTIONUS2009098103
DESCRIPTIONUS2009148502
DESCRIPTIONUS2009175931
DESCRIPTIONUS2009232877
DESCRIPTIONUS2010086529
DESCRIPTIONUS2010093607
INTERNATIONAL-SEARCH-REPORTAU2003204479B
INTERNATIONAL-SEARCH-REPORTEP1935429
INTERNATIONAL-SEARCH-REPORTUS2006159733
INTERNATIONAL-SEARCH-REPORTWO2005038019
OPPOSITIONAU2003204479B
OPPOSITIONUS2006159733
OPPOSITIONWO2005038019

Non-Patent Literature (NPL) Citations (69) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ABDEL-WAHABET, TRANSFUSION, (2006), vol. 46, pages 1279 - 85
DESCRIPTION- AL DIERI ET AL., THROMB HAEMOST, (2002), vol. 88, pages 576 - 82
DESCRIPTION- BAGOT ET AL., THROMB HAEMOST, (2007), vol. 98, pages 1141 - 2
DESCRIPTION- BLOME ET AL., J THROMB HAEMOST, (2005), vol. 93, pages 1101 - 7
DESCRIPTION- BRITISH JOURNAL OF ANAEVTHESICT, (2006), vol. 97, no. 4, pages 460 - 467
DESCRIPTION- BROHI ET AL., J TRAUMA, (2003), vol. 54, pages 1127 - 30
DESCRIPTION- CHARBIT ET AL., J THROMB HAEMOST, (2007), vol. 5, pages 266 - 73
DESCRIPTION- CHOWDHURY, BR J HAEMATOL, (2004), vol. 125, pages 69 - 73
DESCRIPTION- CIAVARELLA ET AL., BR J HAEMATOL, (1987), vol. 67, pages 365 - 8
DESCRIPTION- DARA ET AL., CRIT CARE MED., (2005), vol. 33, pages 2667 - 71
DESCRIPTION- DICKNEITE ET AL., BR J ANAESTH, (2009), vol. 102, pages 345 - 54
DESCRIPTION- FENGER-ERIKSEN ET AL., J THROMB HAEMOST, (2009), vol. 7, pages 1099 - 105
DESCRIPTION- FENGER-ERIKSEN ET AL., J THROMB HAEMOST, (2009), vol. 7, pages 795 - 802
DESCRIPTION- FRIESE, BR J ANAESTH, (2005), vol. 95, pages 172 - 7
DESCRIPTION- FRIES ET AL., ANESTH ANALG, (2006), vol. 102, pages 347 - 51
DESCRIPTION- FRIES ET AL., BRITISH JOURNAL OF ANAESTHESIA, (2006), vol. 97, no. 4, pages 460 - 467
DESCRIPTION- FRIES ET AL., BR J ANAESTH, (2005), vol. 95, pages 172 - 7
DESCRIPTION- GERLACH ET AL., STROKE, (2002), vol. 33, pages 1618 - 23
DESCRIPTION- HEMKER ET AL., PATHOPHYSIOL HAEMOST THROMB, (2002), vol. 32, pages 249 - 253
DESCRIPTION- HES. DICKNEITE ET AL., ANESTH ANALG, (2008), vol. 106, pages 1070 - 7
DESCRIPTION- HIIPPALA ET AL., ANESTH ANALG, (1995), vol. 81, pages 360 - 5
DESCRIPTION- INNERHOFER P ET AL., ANESTH ANALG, (2002), vol. 95, pages 858 - 65
DESCRIPTION- INNERHOFER P ET AL., ANESTH ANALG, (2002), vol. 9, no. 5, pages 5 - 65
DESCRIPTION- KOHLER ET AL., THROMH HAEMOST, (1998), vol. 80, pages 399 - 402
DESCRIPTION- KORTE ET AL., HAMOSTASEOLOGIE, (2006), vol. 26, pages 30 - 5
DESCRIPTION- LUDDINGTON, CLIN LAB HAEMATOL, (2005), vol. 27, pages 81 - 90
DESCRIPTION- MCLOUGHLIN ET AL., ANESTH ANALG, (1996), vol. 83, pages 459 - 65
DESCRIPTION- MITTERMAYR ET AL., ANESTH ANALG, (2007), vol. 105, pages 905 - 17
DESCRIPTION- MITTERMAYR ET AL., ANESTH ANALG, (2007), vol. 1, no. 05, pages 905 - 17
DESCRIPTION- P ET AL., ANESTH ANALG, (2002), vol. 95, pages 858 - 65
DESCRIPTION- SARANI ET AL., CRIT CARE MED, (2008), vol. 36, pages 11114 - 8
DESCRIPTION- SCALEA ET AL., ANN SURG, (2008), vol. 248, pages 578 - 84
DESCRIPTION- SINGBARTL, ANESTH ANALG, (2003), vol. 96, pages 929 - 35
DESCRIPTION- SINGBARTL ET AL., ANESTH ANALG, (2003), vol. 96, pages 929 - 35
DESCRIPTION- SPAHN ET AL., CRIT CARE, (2007), vol. 11, page R17
DESCRIPTION- SPAHN ET AL., CRIT CARE, (2007), vol. 11, page RI7
DESCRIPTION- SPERRY ET AL., J TRAUMA, (2008), vol. 64, pages 9 - 14
DESCRIPTION- SPERRY JL ET AL., J TRAUMA, (2008), vol. 64, pages 9 - 14
DESCRIPTION- STAINSBY ET AL., BR J ANAEST, (2000), no. 85, pages 487 - 91
DESCRIPTION- STAINSBY ET AL., BR JHAEMATOT, (2006), vol. 135, pages 634 - 41
DESCRIPTION- STANWORTH ET AL., BR J HAEMATOL, (2004), vol. 126, pages 139 - 52
DESCRIPTION- STAUDINGER ET AL., INTENSIVE CARE MED, (1999), vol. 25, pages 1105 - 10
DESCRIPTION- STINGER ET AL., J TRAUMA, (2008), vol. 64, pages 79 - 85
DESCRIPTION- UCAR ET AL., HEART SURG FORUM, (2007), vol. 10, pages E392 - 6
DESCRIPTION- VELIK-SALCHNER ET AL., J THROMB HAEMOST, (2007), vol. 5, pages 1019 - 25
DESCRIPTION- VELIK-SALCHNER ET AL., THROMB RES, (2006), vol. 117, pages 597 - 602
DESCRIPTION- WARREN ET AL., ANN EMERG MED, (2009), vol. 53, pages 758 - 61
DESCRIPTION- WATSON GA ET AL., J TRAUMA, (2009), vol. 67, pages 221 - 7
INTERNATIONAL-SEARCH-REPORT- IORIO ALFONSO ET AL, "Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors.", COCHRANE DATABASE OF SYSTEMATIC REVIEWS (ONLINE) 2010 LNKD- PUBMED:20687076, (2010), no. 8, doi:10.1002/14651858.CD004449pub3., ISSN 1469-493X, pages 1 - 20, XP002670700 [X] 1-7,23 * the whole document *
INTERNATIONAL-SEARCH-REPORT- LIER H ET AL, "Gerinnungsmanagement bei der Polytraumaversorgung", DER ANAESTHESIST ; ZEITSCHRIFT FÜR ANÄSTHESIE, INTENSIVMEDIZIN, NOTFALLUND KATASTROPHENMEDIZIN, SCHMERZMEDIZIN, SPRINGER, BERLIN, DE, (20091010), vol. 58, no. 10, doi:10.1007/S00101-009-1595-Z, ISSN 1432-055X, pages 1010 - 1026, XP019743584 [XD] 1-6,8,12,13,15-17,22,23 * page 1019 - page 1020 * * page 1024, column 1 - column 2 * * page 1023, Infobox 2, point 4. *
INTERNATIONAL-SEARCH-REPORT- STAUDINGER T ET AL, "Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients.", INTENSIVE CARE MEDICINE OCT 1999 LNKD- PUBMED:10551966, (199910), vol. 25, no. 10, ISSN 0342-4642, pages 1105 - 1110, XP002670697 [XD] 1-6,8,12,13,22,23 * the whole document *
INTERNATIONAL-SEARCH-REPORT- FRIES D ET AL, "Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy - a porcine model", BRITISH JOURNAL OF ANAESTHESIA, (200610), vol. 97, no. 4, ISSN 0007-0912, pages 460 - 467, XP002670696 [XD] 1-6,8,12-17,19-23 * the whole document *
INTERNATIONAL-SEARCH-REPORT- SCHÖCHL H ET AL, "Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate.", ANAESTHESIA FEB 2010 LNKD- PUBMED:19995349, (201002), vol. 65, no. 2, ISSN 1365-2044, pages 199 - 203, XP002670698 [X] 1-6,12,13,16,17,21-23 * page 200 - page 201 *
INTERNATIONAL-SEARCH-REPORT- DICKNEITE GERHARD ET AL, "Characterization of the coagulation deficit in porcine dilutional coagulopathy and substitution with a prothrombin complex concentrate", ANESTHESIA & ANALGESIA, (200804), vol. 106, no. 4, ISSN 0003-2999, pages 1070 - 1077, XP002670695 [XD] 1-6,14,15,20,22,23 * the whole document *
INTERNATIONAL-SEARCH-REPORT- FRANCHINI MASSIMO ET AL, "Prothrombin complex concentrates: an update.", BLOOD TRANSFUSION = TRASFUSIONE DEL SANGUE JUL 2010 LNKD- PUBMED:20671873, (201007), vol. 8, no. 3, ISSN 1723-2007, pages 149 - 154, XP002670699 [X] 1-7,23 * the whole document *
OPPOSITION- DICKNEITE et al., "Prothrombin Complex Concentrate Versus Recombinant Factor VIIa for Reversal of Hemodilutional Coagulopathy in a Porcine Trauma Model", Journal of Trauma: Injury, Infection and Critical Care, (20100500), vol. 68, no. 5, pages 1151 - 1157, XP055441366
OPPOSITION- DICKNEITE et al., "Reconstitution of the thrombin generation potential is essential to ove dilutional coagulapathy", Hamostaseologie, (20080000), vol. 1-2, page A66, XP055441371
OPPOSITION- GANTER et al., "Monitoring Recombinant Factor VIIa Treatment: Efficacy Depends on High Levels of Fibrinogen in a Model of Severe Dilutional Coagulopathy", Zurich Open Repository and Archive, (20080000), pages 1 - 23, XP055441381
OPPOSITION- HANKER DUSEL et al., "Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates", Blood Coagul Fibrinolysis, (20040000), vol. 15, pages 405 - 411, XP055441342
OPPOSITION- HIMMELSPACH et al., "A Fully Recombinant Partial Prothrombin Complex Effectively Bypasses fVIII In Vitro and In Vivo", Thromb Haemost, (20020000), vol. 88, pages 1003 - 1011, XP055441352
OPPOSITION- TURECEK et al., "Factor Xa and prothrombin: mechanism of action of FEIBA", Vox Sang, (19990000), vol. 77, no. suppl.1, pages 72 - 79, XP055441348
OPPOSITION- LYNN et al., "Updates in the management of severe coagulopathy in trauma patients", Intensive Care Med, (20020000), vol. 28, pages S241 - S247, XP055441357
OPPOSITION- TSAI et al., "Role of Factor VII in Correcting Dilutional Coagulopathy and Reducing Re-operations for Bleeding Following Non-traumatic Major Gastrointestinal and Abdominal Surgery", J Gastrointest Surg, (20100600), vol. 14, pages 1311 - 1318, XP055441359
OPPOSITION- FRIES et al., "Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model", British Journal of Anaesthesia, (20050000), vol. 95, no. 2, pages 172 - 177, XP055441364
OPPOSITION- FRIES et al., "Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy - a porcine model", British Journal of Anaesthesia, (20060000), vol. 97, pages 460 - 467, XP002670696
OPPOSITION- SCHOCHL et al., "Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate", Anaesthesia, (20090000), vol. 65, pages 199 - 203, XP002670698
OPPOSITION- FENGER-ERIKSEN et al., "Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy", J Thromb Haemos, (20090000), vol. 7, pages 1099 - 1105, XP055441332
OPPOSITION- MITTERLECHNER et al., "Prothrombin complex concentrate and recombinant prothrombin alone or in combination with recombinant factor X and FVIIa in dilutional coagulopathy: a porcine model", Journal of Thrombosis and Haemostasis, (20110000), vol. 9, pages 729 - 737, XP009156896
OPPOSITION- DICKNEITE et al., "Characterization of the coagulation deficit in porcine dilutional coagulopathy and substitution with a prothrombin complex concentrate", Anesth Analg, (20080000), vol. 106, pages 1070 - 1077, XP002670695

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents